
Sign up to save your podcasts
Or
This week on BioTech Nation, Ossium Health co-founder and CEO Kevin Caldwell shares how their breakthrough approach is changing bone marrow transplants. By cryobanking marrow from organ donors, Ossium is reducing wait times, improving access, and preparing for future emergencies. With support from BARDA and promising clinical trial results, this new system could help thousands more receive lifesaving transplants—right when they need them.
4.1
2929 ratings
This week on BioTech Nation, Ossium Health co-founder and CEO Kevin Caldwell shares how their breakthrough approach is changing bone marrow transplants. By cryobanking marrow from organ donors, Ossium is reducing wait times, improving access, and preparing for future emergencies. With support from BARDA and promising clinical trial results, this new system could help thousands more receive lifesaving transplants—right when they need them.
6,241 Listeners
4,244 Listeners
32,095 Listeners
3,420 Listeners
21,977 Listeners
2,172 Listeners
26,350 Listeners
3,379 Listeners
6,671 Listeners
9,336 Listeners
316 Listeners
30 Listeners
15,495 Listeners
3,369 Listeners
1,186 Listeners